ES8404187A1 - Procedimiento para aislar antigeno carcinoembrional a partir de extractos con acido perclorico que contienen al mismo - Google Patents

Procedimiento para aislar antigeno carcinoembrional a partir de extractos con acido perclorico que contienen al mismo

Info

Publication number
ES8404187A1
ES8404187A1 ES524909A ES524909A ES8404187A1 ES 8404187 A1 ES8404187 A1 ES 8404187A1 ES 524909 A ES524909 A ES 524909A ES 524909 A ES524909 A ES 524909A ES 8404187 A1 ES8404187 A1 ES 8404187A1
Authority
ES
Spain
Prior art keywords
proteins
isolation
carcinoembryonic antigen
separated
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES524909A
Other languages
English (en)
Spanish (es)
Other versions
ES524909A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES524909A0 publication Critical patent/ES524909A0/es
Publication of ES8404187A1 publication Critical patent/ES8404187A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00118—Cancer antigens from embryonic or fetal origin
    • A61K39/001182—Carcinoembryonic antigen [CEA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Microbiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES524909A 1982-08-14 1983-08-12 Procedimiento para aislar antigeno carcinoembrional a partir de extractos con acido perclorico que contienen al mismo Expired ES8404187A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823230299 DE3230299A1 (de) 1982-08-14 1982-08-14 Carcinoembryonales antigen, verfahren zu seiner isolierung und seine verwendung

Publications (2)

Publication Number Publication Date
ES524909A0 ES524909A0 (es) 1984-05-01
ES8404187A1 true ES8404187A1 (es) 1984-05-01

Family

ID=6170888

Family Applications (1)

Application Number Title Priority Date Filing Date
ES524909A Expired ES8404187A1 (es) 1982-08-14 1983-08-12 Procedimiento para aislar antigeno carcinoembrional a partir de extractos con acido perclorico que contienen al mismo

Country Status (13)

Country Link
EP (1) EP0102008A3 (en:Method)
JP (1) JPS5950360A (en:Method)
AU (1) AU1796083A (en:Method)
DD (1) DD211714A5 (en:Method)
DE (1) DE3230299A1 (en:Method)
DK (1) DK368783A (en:Method)
ES (1) ES8404187A1 (en:Method)
FI (1) FI832899A7 (en:Method)
GR (1) GR78692B (en:Method)
IL (1) IL69476A0 (en:Method)
NO (1) NO832905L (en:Method)
PT (1) PT77199B (en:Method)
ZA (1) ZA835947B (en:Method)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8317022D0 (en) * 1983-06-23 1983-07-27 Erba Farmitalia Adenocarcinoma related new antigenic determinants
US6013772A (en) * 1986-08-13 2000-01-11 Bayer Corporation Antibody preparations specifically binding to unique determinants of CEA antigens or fragments thereof and use of the antibody preparations in immunoassays
US6949629B2 (en) 2002-03-13 2005-09-27 Aspenbio, Inc. Methods for purifying selected CEA family member proteins

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663684A (en) * 1970-06-01 1972-05-16 Hoffmann La Roche Carcinoembryonic antigen and diagnostic method using radioactive iodine

Also Published As

Publication number Publication date
GR78692B (en:Method) 1984-09-27
ES524909A0 (es) 1984-05-01
DD211714A5 (de) 1984-07-25
ZA835947B (en) 1984-04-25
DK368783D0 (da) 1983-08-12
FI832899L (fi) 1984-02-15
AU1796083A (en) 1985-02-21
JPS5950360A (ja) 1984-03-23
EP0102008A3 (de) 1987-01-28
IL69476A0 (en) 1983-11-30
EP0102008A2 (de) 1984-03-07
PT77199A (de) 1983-09-01
DE3230299A1 (de) 1984-02-16
PT77199B (de) 1986-03-27
NO832905L (no) 1984-02-15
DK368783A (da) 1984-02-15
FI832899A0 (fi) 1983-08-11
FI832899A7 (fi) 1984-02-15

Similar Documents

Publication Publication Date Title
ES2076142T3 (es) Peptidos para el diagnostico de anticuerpos para htlv-iii, su preparacion y uso.
SE440657B (sv) Forfarande for rening av proteiner utnyttjande immunospecifik affinitet
ES2075196T3 (es) Metodo para el uso y la sintesis de peptidos.
DE3382283D1 (de) Monoklonale antikoerper spezifisch gegen das karzinoembryonische antigen.
IT8319234A0 (it) Procedimento per la produzione di anticorpi monoclonali umani.
IT8220140A0 (it) Procedimento per la produzione di sostanze prodotte da cellule, particolarmente di anticorpi esimili.
IT8321093A0 (it) Peptidi.
IT1008038B (it) Procedimento per la separazione di idrocarburi ad insaturazione ali fatica da miscele gassose
NO138424C (no) Mikrokontaktlinse.
DK123094B (da) Fremgangsmåde til fremstilling af N<α(A1)>,N<ɛ(B29)>-bis-(tert.butyloxycarbonyl)-insulin.
DK407987D0 (da) Apolipoprotein b-specifikke monoklonale antistoffer og hybridomer, som producerer disse antistoffer
DE69030494D1 (de) Karzinomverwandtes haptoglobin (hpr)
ES8404187A1 (es) Procedimiento para aislar antigeno carcinoembrional a partir de extractos con acido perclorico que contienen al mismo
NL7413672A (nl) Steriel fluidumsysteem.
DK135722B (da) Analogifremgangsmåde til fremstilling af 11beta,17aalfa,21-trihydroxy-D-homopregn-4-en-3,20-dioner.
DK129088B (da) Fremgangsmåde til fremstilling af peptider.
SE9000931D0 (sv) Antikroppar mot proteiner
NO156064C (no) Ildsted for fast brensel.
DE3485219D1 (de) Tgf-polypeptide, davon derivierte antigene oligopeptide, davon erhaltene antikoerper.
DK130994B (da) Analogifremgangsmåde til fremstilling af 21-(beta-benzoylaminoisobutyryl)-16alfa,17alfa-(p-dimethylaminobenzyliden)-triamcinolon.
ES544306A0 (es) Procedimiento de producir antigenos relacionados con el enlace glicosidico derivados de cancer.
NO834535L (no) Fremgangsmaate for affinitetsrensing under anvendelse av monoklonale antistoffer.
SE418186B (sv) Forfarande for isolering av ett till kancer knutet polypeptidantigen
ES321509A1 (es) Procedimiento para fabricar gonadotropinas muy purificadas mediante cromatografia.
CH555029A (de) Isolierte druckgasschaltanlage.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971001